Evaluation of Glucocorticoids Plus Rituximab in Patients with Newly-Diagnosed or Relapsing IgA Vasculitis

NCT05329090 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

IgA Vasculitis

Interventions

DRUG: Rituximab Injection
DRUG: placebo

Sponsor

Hopital Foch

Collaborators

[object Object]